Dr. Mannion is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Medical Center East Tower 21 S
# 1215
Nashville, TN 37232Phone+1 615-322-6180Fax+1 615-936-2887
Education & Training
- Vanderbilt University Medical CenterFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2007 - 2008
- University of ConnecticutResidency, Otolaryngology - Head and Neck Surgery, 2002 - 2007
- Uconn School Of MedicineClass of 2002
Certifications & Licensure
- NH State Medical License 2008 - Present
- TN State Medical License 2007 - 2026
- AL State Medical License 2020 - 2020
- MA State Medical License 2008 - 2009
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
- Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
Publications & Presentations
PubMed
- 26 citationsTadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma.Adam J Luginbuhl, Jennifer M Johnson, Larry A Harshyne, Alban J Linnenbach, Sanket K Shukla
Clinical Cancer Research. 2022-03-01 - 1 citationsLongitudinal Pattern of Lymphedema and Fibrosis in Patients With Oral Cavity or Oropharyngeal Cancer: A Prospective Study.Jie Deng, Mary S Dietrich, Joseph M Aulino, Robert J Sinard, Kyle Mannion
International Journal of Radiation Oncology, Biology, Physics. 2024-03-15 - 13 citationsDiagnostic approaches to carcinoma of unknown primary of the head and neckWenda Ye, Ethan H Arnaud, Alexander Langerman, Kyle Mannion, Michael C. Topf
European Journal of Cancer Care. 2021-05-01
Press Mentions
- Photoimmunotherapy Offered in Clinical Trial for Recurrent Head and Neck CancerOctober 14th, 2021
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: